SLS
SELLAS Life Sciences Group Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$5.37
+0.34 ▲ +6.76%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$5.37
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.29 | Insider Own | 1.6% | Shs Outstand | 0.14B | Perf Week | -2.89% |
| Market Cap | 0.76B | Forward P/E | - | EPS next Y | -21.79% | Insider Trans | 2.86% | Shs Float | 0.14B | Perf Month | 46.32% |
| Enterprise Value | 0.72B | PEG | - | EPS next Q | -0.06 | Inst Own | 29.58% | Short Float | 35.05% | Perf Quarter | 173.98% |
| Income | -0.03B | P/S | - | EPS this Y | 48% | Inst Trans | - | Short Ratio | 5.44 | Perf Half Y | 184.13% |
| Sales | 0.00B | P/B | 14.72 | EPS next 5Y | 29.75% | ROA | -66.47% | Short Interest | 49.13M | Perf YTD | 42.44% |
| Book/sh | 0.36 | P/C | 17.22 | EPS past 3/5Y | 27.73% 45.94% | ROE | -84.33% | 52W High | -12.54% ($6.14) | Perf Year | 362.93% |
| Cash/sh | 0.31 | P/FCF | - | Sales past 3/5Y | - | ROIC | -56.85% | 52W Low | 464.31% ($0.95) | Perf 3Y | 306.82% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 59.04% | Gross Margin | - | Volatility(W/M) | 10.52% 9.94% | Perf 5Y | -47.66% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.48 | Perf 10Y | -99.98% |
| Dividend Ex-Date | 2011/3/24 | Quick Ratio | 8.28 | EPS Q/Q | 39.87% | Profit Margin | - | RSI (14) | 59.14 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.28 | Sales Q/Q | - | SMA20 | 10.45% ($4.86) | Beta | 2.18 | Target Price | $7.83 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 11000000 | SMA50 | 23.16% ($4.36) | Rel Volume | 0.68 | Prev Close | $5.03 |
| Employees | 15 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 21.77% - | SMA200 | 118.48% ($2.46) | Avg Volume(3M) | 9.03M | Price | $5.37 |
| IPO | 2008/3/12 | Option/Short | Yes/Yes | Trades | 15309 | Volume | 6,103,555 | Change | 6.76% |
뉴스 로딩 중...